Summary
- Current Price
- As of today, ABCL price is $3.19, down -0.93% on
- Current Price All-Time High
- ABCL price is currently -95.56% below its historical high of $71.91 set on
- Market Cap
- ABCL current market cap is $955M, up +13.63% over the past 365 days
- PE Ratio
- ABCL PE ratio is unknown
- Revenue
- ABCL current annual revenue is $28.83M, down -24.17% year-over-year
- Next Earnings
- As of today, the next earnings release for ABCL has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | AbCellera Biologics Inc. |
| Ticker | NASDAQ: ABCL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | abcellera.com |
| Employees | 596 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $3.19 | |
| Price, 1D Change | -0.93% | |
| $955M | ||
| - | ||
| - | ||
| 1.53 | ||
| $29M | ||
| Revenue, 1Y Change | -24.17% | |
| -$0.55 | ||
| EPS, 1Y Change | -9.28% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.55 | ||
| EPS Estimate | N/A | -$0.63 |
| EPS Est. Change | N/A | -14.46% |
| $28.83M | ||
| Revenue Estimate | N/A | $36.29M |
| Revenue Est. Change | N/A | +25.87% |
| Current Price | $3.19 | |
| Price Target | - | $9.50 |
| Price Tgt. Change | - | +197.81% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.47 | -$0.51 | -7.72% | |
| -$0.59 | -$0.55 | +6.68% | |
| -$0.63 | N/A | -14.46% | |
| -$0.64 | N/A | -14.77% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $38.13M | $38.03M | -0.28% | |
| $31.58M | $28.83M | -8.70% | |
| $36.29M | N/A | +25.87% | |
| $60.65M | N/A | +110.35% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $3.19 | |
| $3.98 | ||
| SMA 200 vs Price | +24.62% | |
| $3.63 | ||
| SMA 50 vs Price | +13.77% | |
| 1.53 | ||
| $0.24 | ||
| 44.17 | ||
| 65.57% | ||
| 79.31% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $28.83M | ||
| -$0.55 | ||
| $28.83M | ||
| -236.42% | ||
| -$301.15M | ||
| -1,044.45% | ||
| -$162.86M | ||
| -564.83% | ||
| -$204.15M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 9.81 | ||
| 9.81 | ||
| - | ||
| 4 | ||
| 3.71 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 27.03 | ||
| 0.99 | ||
| -2.55 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.06B | ||
| $156.33M | ||
| $1.36B | ||
| $751.37M | ||
| $154.58M | ||
| $76.61M | ||
| $65.36M | ||
| $4.62M | ||
| $34.35M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $329.98M | ||
| $329.98M | ||
| $97.00M | ||
| $85.49M | ||
| $97.00M | ||
| $0.00 | ||
| -$37.54M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$108.56M | ||
| $121.41M | ||
| $12.77M | ||
| $78.40M | ||
| -$186.95M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Leerink Partners | → | |
| Stifel | → | |
| Keybanc | → | |
| Truist Securities | → | |
| Stifel | → | |
| Keybanc | → | |
| Benchmark | → | |
| Stifel | → | |
| Keybanc | → | |
| Stifel | → |
Analyst sentiment
Institutional ownership
Screeners with ABCL
FAQ
What is the ticker symbol for AbCellera Biologics Inc.?
The ticker symbol for AbCellera Biologics Inc. is NASDAQ:ABCL
Does AbCellera Biologics Inc. pay dividends?
No, AbCellera Biologics Inc. does not pay dividends
What sector is AbCellera Biologics Inc. in?
AbCellera Biologics Inc. is in the Healthcare sector
What industry is AbCellera Biologics Inc. in?
AbCellera Biologics Inc. is in the Biotechnology industry
What country is AbCellera Biologics Inc. based in?
AbCellera Biologics Inc. is headquartered in Canada
When did AbCellera Biologics Inc. go public?
AbCellera Biologics Inc. initial public offering (IPO) was on December 11, 2020
Is AbCellera Biologics Inc. in the S&P 500?
No, AbCellera Biologics Inc. is not included in the S&P 500 index
Is AbCellera Biologics Inc. in the NASDAQ 100?
No, AbCellera Biologics Inc. is not included in the NASDAQ 100 index
Is AbCellera Biologics Inc. in the Dow Jones?
No, AbCellera Biologics Inc. is not included in the Dow Jones index
When was AbCellera Biologics Inc. last earnings report?
AbCellera Biologics Inc.'s most recent earnings report was on February 24, 2026
When does AbCellera Biologics Inc. report earnings?
The date for AbCellera Biologics Inc.'s next earnings report has not been announced yet
Data Sources & References
- ABCL Official Website www.abcellera.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1703057/000170305725000025/0001703057-25-000025-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1703057/000162828025008689/0001628280-25-008689-index.htm
- ABCL Profile on Yahoo Finance finance.yahoo.com/quote/ABCL
- ABCL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abcl
